David J Yvars Group Neuronetics, Inc. Transaction History
David J Yvars Group
- $155 Million
- Q4 2024
A detailed history of David J Yvars Group transactions in Neuronetics, Inc. stock. As of the latest transaction made, David J Yvars Group holds 46,325 shares of STIM stock, worth $109,790. This represents 0.04% of its overall portfolio holdings.
Number of Shares
46,325
Previous 31,500
47.06%
Holding current value
$109,790
Previous $23,000
200.0%
% of portfolio
0.04%
Previous 0.01%
Shares
17 transactions
Others Institutions Holding STIM
# of Institutions
49Shares Held
13MCall Options Held
30.1KPut Options Held
0-
Kent Lake Pr LLC Anasco, PR2.08MShares$4.92 Million0.63% of portfolio
-
Kent Lake Capital LLC Mill Valley, CA1.74MShares$4.12 Million1.44% of portfolio
-
Cannell Capital LLC Alta, WY1.31MShares$3.11 Million0.23% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.3MShares$3.08 Million0.0% of portfolio
-
Masters Capital Management LLC Atlanta, GA1.2MShares$2.84 Million0.05% of portfolio
About Neuronetics, Inc.
- Ticker STIM
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 27,022,800
- Market Cap $64M
- Description
- Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive diso...